RFK Jr vs DTC advertising
Even a broken clock is right twice a day.
Continue reading RFK Jr vs DTC advertising
Even a broken clock is right twice a day.
Continue reading RFK Jr vs DTC advertising
Just a note to say those following the EpiPen discussions/debates might find the article “Reverse Voxsplaining: Drugs vs. Chairs” of interest. Author Scott Alexander makes some comparisons between the pricing of EpiPens and the pricing of chairs and in the process demonstrates just how absurd our regulatory system is. But then, you already knew that, … Continue reading More on EpiPens
I know all about pharmaceutical pricing. I know big pharmaceutical companies can charge a fortune for a new drug. They attribute it to R&D (research & development) costs of bringing a new drug to market. That’s fine with me. They’re entitled to recoup their expenses and we need the continued development of new drugs. But … Continue reading On Big Pharma, price gouging, and immorality
Iodine, a new online database of both prescription and non-prescription drug information, launched today. Users can look up a drug and read about its efficacy, side effects, warnings, and costs. Also included is a consumer-friendly version of the drug’s package insert. In addition, the site provides data from other consumers about their experiences with the drug. It’s an ambitious project, … Continue reading Iodine: Just what the doctor ordered?
I just saw a commercial for a “new” prescription drug. Only it isn’t. Not really. Intermezzo is “for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.” There is nothing new about this drug except its name. It is zolpidem — generic Ambien. But because you dissolve it under your … Continue reading Intermezzo, another ‘new’ drug that isn’t
(Updated May 19, 2013)Talk about shocked and surprised. I was at the pharmacy today to pick up a couple of prescriptions and was told that the generic form of Dyazide (a diuretic or so-called “water pill”) was on back order. It seems there’s a shortage of its two active ingredients, triamterene and hydrocholorothiazide. A shortage? … Continue reading Would you believe … a triamterene shortage